Kura Oncology (KURA) Assets Average (2011 - 2026)

Kura Oncology (KURA) has 16 years of Assets Average data on file, last reported at $695.5 million in Q1 2026.

• On a quarterly basis, Assets Average fell 7.51% year-over-year to $695.5 million in Q1 2026; TTM through Mar 2026 was $695.5 million, a 7.51% decrease from a year earlier, with the FY2025 full-year figure at $749.3 million, up 23.94% from the prior year.
• Assets Average for Q1 2026 stood at $695.5 million, roughly flat from $693.9 million in the prior quarter.
• Over the last five years, Assets Average for KURA reached as high as $752.0 million in Q1 2025 and fell as low as $441.1 million in Q1 2023.
• Historically, Assets Average has averaged $554.9 million across 5 years, with a median of $501.4 million in 2024.
• Across the five-year window, Assets Average declined 19.77% in 2022 and surged 49.97% in 2025, its largest moves.
• Year by year, Assets Average stood at $452.1 million in 2022, then advanced by 2.04% to $461.4 million in 2023, then jumped by 34.28% to $619.5 million in 2024, then grew by 12.01% to $693.9 million in 2025, then climbed by 0.23% to $695.5 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $695.5 million in Q1 2026, $693.9 million in Q4 2025, and $665.9 million in Q3 2025.